The project proposes the development of a new form of vaccines, namely the creation of a universal nanopic platform based on a recombinant protein-Type 2 protein (HPIV2) virus, which will be a protein non-infectious carrier on antigene determinants of other pathogenic viruses. These solutions have superior technological characteristics against potential substitutes and today’s competing products, primarily from the efficiency point of view.